Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hurteloup

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
British Journal of Haematology|September 1, 1992
Intensive induction chemotherapy in elderly patients. The BGMT GroupJ Reiffers, F Huguet, A M Stoppa, et al.
Progress in Clinical and Biological Research|January 1, 1985
Preoperative chemotherapy in the treatment of inflammatory breast cancerR Keiling, N Guiochet, H Calderoli, et al.
Gastroenterologie Clinique Et Biologique|October 1, 1981
[Malignant gastric lymphoma or undifferentiated carcinoma? Orientation by the response to treatment]J F Bosset, E Pélissier, G Marquet, et al.
Leukemia|March 1, 1990
Pharmacokinetics of idarubicin after oral administration in elderly leukemic patientsJ Robert, F Rigal-Huguet, S Huet, et al.
American Journal of Clinical Oncology|June 1, 1993
Inflammatory breast cancer. Pilot study of intensive induction chemotherapy (FEC-HD) results in a high histologic response rateB Chevallier, H Roche, J P Olivier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1992
Pharmacokinetics and metabolism of 4'-iodo-4'-deoxy-doxorubicin in humansJ Robert, J P Armand, S Huet, et al.
Seminars in Oncology|April 1, 1995
Vinorelbine (Navelbine) in the treatment of breast cancer: the European experienceP Fumoleau, T Delozier, J M Extra, et al.
Cancer Treatment Reports|June 1, 1985
Comparative pharmacokinetics and metabolism of doxorubicin and epirubicin in patients with metastatic breast cancerJ Robert, P Vrignaud, T Nguyen-Ngoc, et al.
European Journal of Haematology|February 1, 1989
Treatment of acute myeloid leukemia in elderly patients with oral idarubicin as a single agentJ L Harousseau, F Rigal-Huguet, P Hurteloup, et al.
Leukemia Research|January 1, 1987
Pharmacokinetics of idarubicin after daily intravenous administration in leukemic patientsJ Robert, F Rigal-Huguet, J L Harousseau, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
British Journal of Haematology|September 1, 1992
Intensive induction chemotherapy in elderly patients. The BGMT GroupJ Reiffers, F Huguet, A M Stoppa, et al.
Progress in Clinical and Biological Research|January 1, 1985
Preoperative chemotherapy in the treatment of inflammatory breast cancerR Keiling, N Guiochet, H Calderoli, et al.
Gastroenterologie Clinique Et Biologique|October 1, 1981
[Malignant gastric lymphoma or undifferentiated carcinoma? Orientation by the response to treatment]J F Bosset, E Pélissier, G Marquet, et al.
Leukemia|March 1, 1990
Pharmacokinetics of idarubicin after oral administration in elderly leukemic patientsJ Robert, F Rigal-Huguet, S Huet, et al.
American Journal of Clinical Oncology|June 1, 1993
Inflammatory breast cancer. Pilot study of intensive induction chemotherapy (FEC-HD) results in a high histologic response rateB Chevallier, H Roche, J P Olivier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1992
Pharmacokinetics and metabolism of 4'-iodo-4'-deoxy-doxorubicin in humansJ Robert, J P Armand, S Huet, et al.
Seminars in Oncology|April 1, 1995
Vinorelbine (Navelbine) in the treatment of breast cancer: the European experienceP Fumoleau, T Delozier, J M Extra, et al.
Cancer Treatment Reports|June 1, 1985
Comparative pharmacokinetics and metabolism of doxorubicin and epirubicin in patients with metastatic breast cancerJ Robert, P Vrignaud, T Nguyen-Ngoc, et al.
European Journal of Haematology|February 1, 1989
Treatment of acute myeloid leukemia in elderly patients with oral idarubicin as a single agentJ L Harousseau, F Rigal-Huguet, P Hurteloup, et al.
Leukemia Research|January 1, 1987
Pharmacokinetics of idarubicin after daily intravenous administration in leukemic patientsJ Robert, F Rigal-Huguet, J L Harousseau, et al.
Pageof 4